341028-37-3Cc1sc[n+](CC(=O)c2ccccc2)c1C.[Cl-]MKOMESMZHZNBIZ-UHFFFAOYSA-M341028-37-3DTXSID60955648CHEMBL2107309Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Danger
H302 (97.5%): Harmful if swallowed [Warning Acute toxicity, oral]
P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P354+P338, P317, P319, P321, P330, P332+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 40 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
UsesPrevention and treatment of cardiovascular complications of aging, diabetes, and end stage renal disease; diabetic multisymptom pathology (other than cardiovascular) including retinopathy, neuphropathy, neuropathy, and ulcers (advanced glycosylation endpr.
UsesAlagebrium Chloride is used in the treatment of obesity resulting from a diet high in both fat and AGE that causes renal impairment in animals. Alagebrium inhibits AGE-mediated formation of reactive oxygen species (ROS), extracellular signal-regulated kinase phosphorylation, and cyclooxygenase-2 expression.
No reaction records under the current filter.
Loading…